Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Evaluation of ¹⁸F-fluorodeoxyglucose uptake in enlarged mediastinal lymph nodes in patients with lung cancer.

Ji C, Zhang B, Zhu W, Ling C, Hu X, Chen Y, Huang J, Guo L, Xu H.

Int J Clin Exp Pathol. 2014 Oct 15;7(11):8227-34.

2.

A comparison of endoscopic ultrasound guided biopsy and positron emission tomography with integrated computed tomography in lung cancer staging.

Larsen SS, Vilmann P, Krasnik K, Dirksen A, Clementsen P, Skov BG, Jacobsen GK, Lassen U, Eigtved A, Berthelsen AK, Mortensen J, Hoejgaard L.

Curr Health Sci J. 2009 Jan;35(1):5-12.

3.

Clinical application of positron emission tomography in designing radiation fields in non-small cell lung cancer patients.

Lin A, Wood C, Hill-Kayser C, Mick R, Kaiser L, Metz J.

Exp Ther Med. 2010 Nov;1(6):1027-1033.

4.

Colorimetric immunoassay for detection of tumor markers.

Yin Y, Cao Y, Xu Y, Li G.

Int J Mol Sci. 2010;11(12):5077-94. doi: 10.3390/ijms11125077.

5.

Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging.

Sieren JC, Ohno Y, Koyama H, Sugimura K, McLennan G.

J Magn Reson Imaging. 2010 Dec;32(6):1353-69. doi: 10.1002/jmri.22383. Review.

6.

Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease.

Ryu SY, Kim K, Kim Y, Park SI, Kim BJ, Kim MH, Choi SC, Lee ED, Lee KH, Kim BI.

J Korean Med Sci. 2010 Jul;25(7):1029-33. doi: 10.3346/jkms.2010.25.7.1029.

7.

MR/CT image fusion of the spine after spondylodesis: a feasibility study.

Karlo CA, Steurer-Dober I, Leonardi M, Pfirrmann CW, Zanetti M, Hodler J.

Eur Spine J. 2010 Oct;19(10):1771-5. doi: 10.1007/s00586-010-1430-x.

8.

Monte Carlo simulations of absorbed dose in a mouse phantom from 18-fluorine compounds.

Taschereau R, Chatziioannou AF.

Med Phys. 2007 Mar;34(3):1026-36.

9.

Advances in positron emission tomographic imaging of lung cancer.

Chen DL, Dehdashti F.

Proc Am Thorac Soc. 2005;2(6):541-4, 512. Review.

10.

Oncologic positron emission tomography: a surgical perspective.

Moore TO, Griffeth LK.

Proc (Bayl Univ Med Cent). 2003 Jan;16(1):13-20. No abstract available.

11.

Subtle pleural metastasis without large effusion in lung cancer patients: preoperative detection on CT.

Hwang JH, Song KS, Park SI, Lim TH, Kwon KH, Goo DE.

Korean J Radiol. 2005 Apr-Jun;6(2):94-101.

12.

18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.

Laking G, Price P.

Thorax. 2001 Sep;56 Suppl 2:ii38-44. Review. No abstract available.

13.

Bone marrow involvement in breast cancer detected by positron emission tomography.

Lewanski CR, Kaplan GR, Potter J, Richman P, Ashford RF, Wong WL.

J R Soc Med. 1999 Apr;92(4):193-5. No abstract available.

14.

Positron emission tomography (PET) in the evaluation of patients with cancer.

Godwin HA Jr, Zuger JH.

Trans Am Clin Climatol Assoc. 1999;110:181-94. Review. No abstract available.

15.

Strategy and cost in investigating solitary pulmonary nodules.

Gould MK, Lillington GA.

Thorax. 1998 Aug;53 Suppl 2:S32-7. Review.

16.

Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients.

Ahmad A, Barrington S, Maisey M, Rubens RD.

Br J Cancer. 1999 Feb;79(3-4):478-82.

18.

Current role of positron emission tomography in thoracic oncology.

Lowe VJ, Naunheim KS.

Thorax. 1998 Aug;53(8):703-12. Review.

19.

Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).

Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN.

Thorax. 1997 May;52(5):438-41.

20.

Evaluation of pleural diseases with FDG-PET imaging: preliminary report.

Bury T, Paulus P, Dowlati A, Corhay JL, Rigo P, Radermecker MF.

Thorax. 1997 Feb;52(2):187-9.

Items per page

Supplemental Content

Support Center